Challenges in conducting multicenter clinical trials in female sexual dysfunction: baseline differences between study populations.
Female sexual dysfunction (FSD) presents several unique challenges in the design and interpretation of multicenter clinical trials. This paper discusses the issue of baseline differences between study populations, using the demographic data of a recent publication describing the validation of a new questionnaire for the evaluation of FSD.
Islam
A
A
Target Health Inc., 305 Madison Avenue, 25th Floor, New York, NY 10165, USA. aislam@TargetHealth.com
Mitchel
J T
JT
Hays
J
J
Rosen
R
R
D'Agostino
R
R
D000328:Adult; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011687:Purines; D020018:Sexual Dysfunctions, Psychological / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D000068677:Sildenafil Citrate; D013450:Sulfones; D011795:Surveys and Questionnaires
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate